High-dose intravenous vitamin C reduce C-reactive protein levels, fluid retention, and APACHE II scores in patients with moderately severe acute pancreatitis: a prospective, randomized, double-blinded, placebo-controlled study. [PDF]
Zhao B +20 more
europepmc +1 more source
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. [PDF]
Paller CJ +22 more
europepmc +1 more source
Related searches:
Intravenous vitamin C for COVID-19: no benefit
Drug and Therapeutics BulletinAbstract Overview of: LOVIT-COVID Investigators. Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials. JAMA 2023;330:1745-59.
openaire +2 more sources
Intravenous ascorbic acid (vitamin C) causing pseudohyperglycemia
Clinical Toxicology, 2023Jeremy Hardin +2 more
openaire +2 more sources
The potential role of intravenous vitamin C monotherapy in critical illness
Journal of Parenteral and Enteral Nutrition, 2022Christian Stoppe +4 more
openaire +2 more sources
Intravenous vitamin C harmful in adults with sepsis
Journal of Paediatrics and Child Health, 2022openaire +2 more sources
Intravenous vitamin C in the treatment of shingles
European Journal of Integrative Medicine, 2012Schencking Martin +6 more
openaire +1 more source
Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.
Puerto Rico health sciences journal, 2004A series of seven cases are presented in which intravenous vitamin C has been used as antineoplastic agent in the treatment of different types of cancers. The cancers cases reviewed are the following: Renal cell carcinoma (2), Colorectal cancer (1), Pancreatic cancer (1), Non-Hodgkin's lymphoma (2) and breast cancer (1).
Hugh D, Riordan +9 more
openaire +1 more source
Vitamin‐C in blood and urine by intravenous saturation
Acta Medica Scandinavica, 1939LEO SKURNIK, HEINZ GROTH
openaire +1 more source
Roundtable: Intravenous Vitamin C for Treating Cancer
Alternative and Complementary Therapies, 2009Jack Challem +4 more
openaire +1 more source

